0.00 - 0.01
0.00 - 0.02
1.30M / 496.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
12.48%
Revenue growth under 50% of LBL.AX's 27.40%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
18.99%
Gross profit growth at 50-75% of LBL.AX's 25.87%. Martin Whitman would question if cost structure or brand is lagging.
70.35%
EBIT growth below 50% of LBL.AX's 197.20%. Michael Burry would suspect deeper competitive or cost structure issues.
70.35%
Operating income growth under 50% of LBL.AX's 197.20%. Michael Burry would be concerned about deeper cost or sales issues.
107.71%
Net income growth at 50-75% of LBL.AX's 158.96%. Martin Whitman would question fundamental disadvantages in expenses or demand.
100.00%
EPS growth at 50-75% of LBL.AX's 155.56%. Martin Whitman would suspect a lag in operational efficiency or a higher share count.
100.00%
Diluted EPS growth at 50-75% of LBL.AX's 155.56%. Martin Whitman would question if share issuance or modest net income gains hamper progress.
82.12%
Share count expansion well above LBL.AX's 1.49%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
82.12%
Diluted share count expanding well above LBL.AX's 1.49%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
-274.48%
Negative OCF growth while LBL.AX is at 0.00%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-14.34%
Negative FCF growth while LBL.AX is at 70.33%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-96.30%
Negative 10Y revenue/share CAGR while LBL.AX stands at 233.29%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-57.39%
Negative 5Y CAGR while LBL.AX stands at 233.29%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-55.96%
Negative 3Y CAGR while LBL.AX stands at 233.29%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-103.53%
Negative 10Y OCF/share CAGR while LBL.AX stands at 0.00%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
83.39%
OCF/share CAGR of 83.39% while LBL.AX is zero. Bruce Berkowitz would see if modest momentum can translate into a bigger competitive lead.
-123.37%
Negative 3Y OCF/share CAGR while LBL.AX stands at 0.00%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
No Data
No Data available this quarter, please select a different quarter.
103.52%
Below 50% of LBL.AX's 400.23%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
126.47%
Below 50% of LBL.AX's 400.23%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-94.74%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
580.87%
SG&A growth well above LBL.AX's 4.82%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.